New cell infusion aims to prepare leukemia patients for life-saving transplant

NCT ID NCT07297173

First seen Jan 11, 2026 · Last updated May 14, 2026 · Updated 19 times

Summary

This early-phase study tests whether adding a special type of immune cell infusion to chemotherapy can safely help prepare people with relapsed or refractory leukemia for a stem cell transplant. Only 5 participants will be enrolled to check for side effects like graft-versus-host disease and infections. The goal is to see if this approach can improve transplant success.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for REFRACTORY LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Hematology, the Fifth Medical Center of Chinese PLA General Hospital

    RECRUITING

    Beijing, 100071, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.